This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastrointestinal oncology is a branch of oncology that deals with the diagnosis and treatment of cancers of the gastrointestinal tract, including the stomach, small intestine, colon, and rectum. Gastrointestinal cancers are the third most common type of cancer, and they are the leading cause of cancer-related death in men and women in the United States. Gastrointestinal cancers can be divided into two main types: gastric cancer and colorectal cancer. Gastric cancer is the most common type of gastrointestinal cancer, and it accounts for about 60% of all gastrointestinal cancers. Colorectal cancer is the second most common type of gastrointestinal cancer, and it accounts for about 30% of all gastrointestinal cancers. Other types of gastrointestinal cancer include pancreatic cancer, hepatocellular cancer, and biliary tract cancer. Gastrointestinal cancer is typically diagnosed when it has advanced beyond the early stage, which is known as Stage I. Stage I gastric cancer is generally treated with surgery, chemotherapy, and radiation. Stage II gastric cancer is treated with surgery, chemotherapy, and radiation. Stage III gastric cancer is treated with surgery, chemotherapy, and radiation. Stage IV gastric cancer is generally treated with chemotherapy and radiation. Stage IV gastric cancer is rarely treated with surgery. Gastrointestinal cancer can be highly responsive to treatment, and most patients who are treated will survive for at least five years. However, gastrointestinal cancer is one of the most deadly types of cancer, and the five-year survival rate for patients who are treated is only about 60%. There are many different types of gastrointestinal cancer, and each type of gastrointestinal cancer is treated differently. However, the majority of gastrointestinal cancers are treated using a combination of surgery, chemotherapy, and radiation. There are a number of different types of gastrointestinal cancer, and each type of gastrointestinal cancer is treated differently. However, the majority of gastrointestinal cancers are treated using a combination of surgery, chemotherapy, and radiation.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States